Vimarsana
Biggest News Aggregation in the World

Page 8 - Corticosteroids News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Corticosteroids. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Corticosteroids Today - Breaking & Trending Today

Severe Asthma Patients Often Unresponsive to Conventional Treatments, Scientists Investigate Why - Vimarsana News

Severe Asthma Patients Often Unresponsive to Conventional Treatments, Scientists Investigate Why

Patients with severe asthma frequently respond poorly to conventional treatments and scientists find the reason for the unresponsiveness. Read to learn more.

Animal behaviour: Female mice release banana-scented urine when pregnant to deter males - Vimarsana News

Animal behaviour: Female mice release banana-scented urine when pregnant to deter males

Pregnant and lactating female mice release a banana-smelling chemical in their urine that is thought to stress out males so they don’t commit infanticide

Asthma Increases the Risk of Obesity Among Adults: Study - Vimarsana News

Asthma Increases the Risk of Obesity Among Adults: Study

Adults with asthma are more likely to become obese later in life. The risk is higher among those with non-allergic asthma, with longer disease duration.

What is Vogt-Koyanagi-Harada disease? - Vimarsana News

What is Vogt-Koyanagi-Harada disease?

This article explains Vogt−Koyanagi−Harada disease, a vision-threatening multisystem autoimmune condition, in which symptoms manifest in stages.

Almirall, S.A.: Almirall: Lebrikizumab Combined with Topical Corticosteroids Showed Significant Improvements in Disease Severity for Atopic Dermatitis - Vimarsana News

Almirall, S.A.: Almirall: Lebrikizumab Combined with Topical Corticosteroids Showed Significant Improvements in Disease Severity for Atopic Dermatitis

- Skin clearance and itch, key signs and symptoms of atopic dermatitis, were significantly improved with lebrikizumab treatment in combination with TCS BARCELONA, Spain, April 11, 2022